Postdoc: Pancreatic Organoids & Multiomics Research

Unist; Poznań; Hybrid; PLN 91,000 - 109,000; Full time

Benefits offered by this job

Life insurance

Pension plan

Savings and investment fund

Disability support

Job summary

Adam Mickiewicz University, Poznań invites applications for a postdoctoral fellow in the Laboratory of Stem Cell Biology and Regenerative Medicine, part of an OPUS project funded by NCN. The successful candidate will study changes in pancreatic organoids derived from patients with type 2 diabetes using multi-omics techniques, advancing strategies for cell and gene therapies.

The role involves differentiating human stem cells into pancreatic beta cells, applying genome editing, single-cell RNA

Qualifications

• PhD in molecular biology or a related field; must be fulfilled at signing of the employment contract.
• Experience in multiomics analyses.
• Experience in stem cell differentiation, pancreatic physiology, genomic editing with CRISPR/Cas9, or single-cell RNA sequencing is a plus.
• Strong publication record.
• Fluent English in writing and speaking.
• Must meet NCN OPUS competition criteria.

Responsibilities

• Study changes in pancreatic organoids derived from type 2 diabetes patients using multi-omics techniques.
• Collaborate with Prof. Małgorzata Borowiak's team at AMU and teams at the University of Helsinki; possible short-term internships.

Skills

Multiomics analyses

Stem cell differentiation

CRISPR/Cas9 editing

Single-cell RNA sequencing

English proficiency

Independence and reliability

Teamwork

Education

PhD in molecular biology or related field

Tools

CRISPR/Cas9

Job description

Adam Mickiewicz University, Poznań invites applications for a postdoctoral fellow in the Laboratory of Stem Cell Biology and Regenerative Medicine, part of an OPUS project funded by NCN. The successful candidate will study changes in pancreatic organoids derived from patients with type 2 diabetes using multi-omics techniques, advancing strategies for cell and gene therapies.

The role involves differentiating human stem cells into pancreatic beta cells, applying genome editing, single-cell RNA